Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Deloitte
US Army
Healthtrust
Dow
Express Scripts
Medtronic
Julphar
Fish and Richardson
Farmers Insurance

Generated: August 19, 2017

DrugPatentWatch Database Preview

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Pioglitazone Hydrochloride And Glimepiride, and when can generic versions of Pioglitazone Hydrochloride And Glimepiride launch?

Pioglitazone Hydrochloride And Glimepiride is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.

Summary for Tradename: PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list1
Clinical Trials: see list105,652
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
glimepiride; pioglitazone hydrochloride
TABLET;ORAL201049-001Jan 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
glimepiride; pioglitazone hydrochloride
TABLET;ORAL201049-002Jan 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
US Department of Justice
Accenture
Colorcon
Mallinckrodt
Teva
Dow
Federal Trade Commission
Fish and Richardson
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot